Page last updated: 2024-10-24

bupivacaine and Vitreoretinopathy, Proliferative

bupivacaine has been researched along with Vitreoretinopathy, Proliferative in 1 studies

Bupivacaine: A widely used local anesthetic agent.
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide : A piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline.
bupivacaine : A racemate composed of equimolar amounts of dextrobupivacaine and levobupivacaine. Used (in the form of its hydrochloride hydrate) as a local anaesthetic.

Vitreoretinopathy, Proliferative: Vitreoretinal membrane shrinkage or contraction secondary to the proliferation of primarily retinal pigment epithelial cells and glial cells, particularly fibrous astrocytes, followed by membrane formation. The formation of fibrillar collagen and cellular proliferation appear to be the basis for the contractile properties of the epiretinal and vitreous membranes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sharma, T1
Gopal, L1
Parikh, S1
Shanmugam, MP1
Badrinath, SS1
Mukesh, BN1

Other Studies

1 other study available for bupivacaine and Vitreoretinopathy, Proliferative

ArticleYear
Parabulbar anesthesia for primary vitreoretinal surgery.
    Ophthalmology, 1997, Volume: 104, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Local; Anesthetics, Local; Bupivacaine; Drug Combination

1997